Class II · Moderate risk
B-Complex (30 Ml)
Lack of Assurance of Sterility
Is Thiamine recalled?
Yes — there is an active recall. 12 ongoing FDA recalls mention Thiamine (39 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Thiamine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Thiamine recalls on record
none so far in 2026; 39 on record, newest first
Class II · Moderate risk
Amino Energy Cocktail
Lack of Assurance of Sterility
Class II · Moderate risk
Thiamine 100 Mg/Ml W/Pres
Lack of Assurance of Sterility
Class II · Moderate risk
Thiamine 100 Mg/Ml
Lack of Assurance of Sterility
Class II · Moderate risk
Pyridoxal 50 Mg/Thiamine 50 Mg/Lidocaine 1% Ns
Lack of Assurance of Sterility
Class II · Moderate risk
Thiamine 100 mg
Lack of Assurance of Sterility
Class II · Moderate risk
Thiamine HCl Injection
Lack of Assurance of Sterility
Class II · Moderate risk
Thiamine 100 mg/ ml vials
Lack of sterility assurance.
Class II · Moderate risk
Lipotropic Gold
Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Class II · Moderate risk
HYDROXOCOBALAMIN/THIAMINE* 1 mg/100 mg/mL INJECTABLE
Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.
Class II · Moderate risk
Thiamine HCL
Labeling: Label Mixup: THIAMINE HCL, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs: SIMVASTATIN, Tablet, 5 mg, NDC 00093715298, Pedigree: AD65323_13, EXP: 5/29/2014; CALCIUM CARBONATE +D3, Tablet, 600 mg/400 units, NDC 00904323392, Pedigree: AD54576_1, EXP: 5/20/2014; BUPRENORPHINE HCL SL, Tablet, 2 mg, NDC 00054017613, Pedigree: AD54478_1, EXP: 5/20/2014; P
Class II · Moderate risk
Thiamine Hydrochloride Injection
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Class II · Moderate risk
Thiamine HCL 100mg/Ml Injectable 300 Ml 360 Ml 450 Ml
Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Class I · High risk
Taztia XT (Diltiazem HCl)
Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.